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Abstract
Smoking, as one of the main causes, is a negative factor associated with many diseases. 
The primary objective of the research is to determine the effect of innovation on select-
ed smoking indicators in a sample of countries of the Organization for Economic Co-
operation and Development (OECD). Four variables enter the analytical processing, 
such as Global Innovation Index, Population ratio of daily smokers (age 15+), Daily 
smokers (age 15-24), and Tobacco consumption in grams per capita (age 15+). These 
variables were included in the research from 2011 to 2018. The simple linear regression 
– the Ordinary Least Squares (OLS) model – and correlation analysis – Spearman’s 
rank correlation – was used for statistical processing. The results show that the effect 
of innovation on the ratio of daily smokers over the age of 15 to the total population 
may be considered a highly significant relationship. The effect on the annual tobacco 
consumption per capita is the second most significant relationship, and the effect on 
the ratio of daily smokers over 15 and under 24 years to the total population is the 
least significant compared to the previous two cases. Correlation analysis shows similar 
outputs. All these relationships may be considered negative. It is possible to talk about 
the lost innovation potential associated with smoking, primarily in the productive part 
of the population. A higher level of smoking can be associated with a lower level of in-
novation. Also, innovation negatively affects the tendency to smoke. Therefore, public 
policies should promote a healthy lifestyle.
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INTRODUCTION 
Smoking and tobacco consumption are among the main determi-
nants of public health. Tobacco consumption represents a major 
global threat to avoidable death and morbidity around the world. At 
the same time, this health problem causes economic damage (WHO, 
2013, 2019). These are the reasons why society as a whole should ad-
dress the consequences of smoking. This problem can also be per-
ceived in terms of innovation potential. Marketing tools should be 
used to support the reduction of smoking and innovation in the 
country. Social marketing in the field of public health and market-
ing of technological innovation is well known (Grier & Bryant, 2005; 
Danaher, Hardie, & Putsis, 2001). In this respect, marketing plays an 
important role in terms of health and innovation. This study deals 
with the effect of innovation on selected smoking-related indicators 
in a sample of OECD countries.
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1. LITERATURE REVIEW
Aksoy, Bilgic, Yen, and Urak (2019) identified two 
main effects of addictive (tobacco and alcohol) 
costs in families: the effect related to the reduc-
tion of costs for other common needs (food, edu-
cation, or health) and the indirect effect related to 
increased health care expenditure. This is in line 
with evidence that daily tobacco use is negatively 
related to the expenditure of families on education 
and health care (Do & Bautista, 2015). Another ev-
idence also illustrates a negative economic effect 
of smoking and confirms that smoking is related 
to poor health of population, reduced productivi-
ty, which may threaten the economic development 
(Rice, Hodgson, Sinsheimer, Browner, & Kopstein, 
1984; Max, Sung, Tucker, & Stark, 2011). There 
are many negative effects of smoking on health, 
which may lead to cardiovascular and cutane-
ous damage (Kallas, Li, & Petri, 2019; Gavurova, 
Vagasova, & Grof, 2017; Gavurová, Huculová, & 
Kováč, 2019), respiratory and autoimmune dis-
orders (Arnson, Shoenfeld, & Amital, 2010), risk 
of cancer (Peto, Darby, Deo, Silcocks, Whitley, & 
Doll, 2000; Vineis, Alavanja, Buffler, Fontham et al., 
2004), risk of diabetes (Hu, Manson, Stampfer et al., 
2001; Willi, Bodenmann, Ghali, Faris, & Cornuz, 
2007), risk of coronary heart disease (Stampfer, 
Hu, Manson, Rimm, & Willett, 2000; Critchley 
& Capewell, 2003). Life-long cigarette consumers 
show a higher incidence of common illness, such 
as atherosclerosis and COPD (Yanbaeva, Dentener, 
Creutzberg, Wesseling, & Wouters, 2007). Thun, 
Carter, Feskanich et al. (2013) found that the risk 
of death due to smoking among women continues 
to rise, and the increased risks are currently almost 
the same for men and women, as compared with 
people who are non-smokers. It can also be empha-
sized that the life expectancy of smokers is shorter 
than that of non-smokers (Jha, Landsman, Rostron 
et al., 2013). Based on the above, tobacco consump-
tion negatively affects investment in the develop-
ment of human capital. Addressing the tobacco 
use issue could benefit not only the health and eco-
nomic well-being of smokers and their immediate 
families, but also long-run economic development 
at a societal level (Do & Bautista, 2015). In line 
with this statement, tobacco control is very impor-
tant (Reddy, Yadav, Arora, & Nazar, 2012; Palali & 
van Ours, 2019), and taxation may be one of the 
most cost-effective means of discouraging tobacco 
use (Aksoy, Bilgic, Yen, & Urak, 2019; Chaloupka, 
2013). Tabuchi, Fukui, and Gallus (2019) highlight-
ed a relatively short-term effect of higher cigarette 
prices. On the other hand, Odermatt and Stutzer 
(2015) confirmed that higher prices of cigarettes 
reduce the life satisfaction of likely smokers. Last 
but not least, evidence suggests that smoking cessa-
tion at any age has significantly reduced mortality 
(Thun et al., 2013), and this is the main reason why 
economies should be focused on smoking cessa-
tion. According to Jha et al. (2013), quitting smok-
ing before the age of 40 reduces the risk of death 
from continued smoking by approximately 90%. 
On the other hand, the findings showed that the 
European consumers who started smoking before 
the age of 16 years were less willing to stop smoking 
compared to consumers who started smoking after 
the age of 16 years (Pesce, 2019). Although smoking 
has a decreasing trend in OECD countries (OECD, 
2016), smoking is one of the main public health 
threats, and this issue should be addressed from 
various perspectives, including in terms of innova-
tion and technology. Innovative technology, such as 
smartphones, can be a significant element in health 
care, individual health education, disease self-man-
agement, and remote patient monitoring (Mosa, 
Yoo, & Sheets, 2012). The smoking issue has a large 
potential in using smartphones (B. Hoeppner, 
S. Hoeppner, Seaboyer, Schick et al., 2016; Iacoviello, 
Luo, Klein, Steinerman, Berger et al., 2017; Peiris, 
Wright, News et al., 2019). Ali, Zhang, and Soomro 
(2019) believe that mHealth and QRC technologies 
are modern innovative tools that can help improve 
the health of tobacco consumers in terms of smok-
ing cessation. The authors supported anti-tobacco 
QR codes printed on cigarette packs. According 
to Baskerville, Struik, Hammond et al. (2015), in 
terms of cost-effectiveness, mHealth technology 
can reach a larger part of the population and help 
young adult tobacco consumers to quit smoking. 
The results of other study confirmed that potential-
ly effective behavior change techniques could be 
identified in smoking cessation applications (Ubhi, 
Michie, Kotz et al., 2015), and eHealth and mHealth 
should be developed to support smoking cessation 
(Borrelli, Bartlett, Tooley, Armitage, & Wearden, 
2015). BinDhim, McGeechan, and Trevena (2014) 
also investigated the effectiveness of smartphone 
applications focused on smoking quitting, and the 
results showed that the use of these applications 
for one month leads to abstinence, and in the case 
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of their use for six months, it is possible to speak 
of continuous abstinence from smoking. Reychav, 
McHaney, Hirak, and Merker (2019) confirmed that 
changing unhealthy smoking habits, which play an 
important role in improving health and healthy 
lifestyle habits, can be stimulated by the active in-
volvement and development of modern and inno-
vative technologies. All the technologies mentioned 
above may be characterized as innovative elements 
of modern life, and several studies dealt with their 
effectiveness in health care (Ahlan & Ahmad, 2014; 
Berkowitz, Zullig, Koontz, & Smith, 2017). Thus, 
the innovative aspect of health, especially in smok-
ing, is very important, and innovative technologies 
may affect the number of smokers in the coun-
try. Therefore, the innovative level of the country 
should be highlighted. It is difficult to find studies 
that deal with the macroeconomic view of the re-
lationship between the country’s innovation index 
and the country’s overall smoking status. On the 
other hand, some studies examined responsible in-
novation in health care (Buttigieg, 2019). Totskaya 
and Sadovoy (2014) stated that active development 
of innovation in the area of health care enables the 
transfer of innovative technologies to the real econ-
omy, and promotes integration into the global en-
vironment of innovation. This article emphasizes 
the importance of an innovative view of a specific 
field of health care and deals with a relationship of 
tobacco consumption of the population and inno-
vation index in OECD countries.
2. METHODOLOGY
Based on the mentioned above, it can be conclud-
ed that smoking has consequences for the overall 
economy of the countries. For this reason, it is 
important to focus on the issue of smoking and 
its reduction. The innovation index determines a 
country’s innovation potential from several per-
spectives. In countries with higher innovation 
performance, a lower tendency for smoking and 
tobacco consumption can be expected. The study’s 
primary objective is to determine the effect of in-
novation on selected smoking indicators in a sam-
ple of OECD countries. 
The analyzed data (variables) were collected from 
OECD databases (OECD, 2019a) and reports from 
the Global Innovation Index (GII) (GII, 2019). The 
GII index presents the aggregate innovation po-
tential expressed in 7 areas (institutions, human 
capital and research, infrastructure, marker so-
phistication, business sophistication, knowledge 
and technology outputs, creative outputs). This 
variable was expressed by a value in the theoretical 
interval of 1 to 100, and a higher value represents 
a more positive result for a country. Dependent 
variables included Smors_D%15 – Daily smokers 
(age 15+) – (percent of a population aged 15+ who 
are daily smokers), definition: Daily smokers is 
defined as the percentage of the population aged 
15 years old or over who report that they are dai-
ly smokers; Smors_D%15-24 – Daily smokers (age 
15-24) – (percent of a population aged 15-24 who 
are daily smokers), definition: Daily smokers is de-
fined as the percentage of the population aged 15-
24 years old or over who report that they are daily 
smokers (OECD, 2019b); G_Tob – Tobacco con-
sumption in grams per capita (age 15+) – (grams 
per capita (15+)), definition: Annual consumption 
of tobacco items (e.g., cigarettes, cigars) in grams 
per person aged 15 years old or more (OECD, 
2019c). The above data were collected from 2011 to 
2018 for all OECD countries (36).
Methods of regression analysis – simple linear re-
gression OLS – was used for statistical processing. 
Based on the Gauss-Markov theorem, the primary 
focus was on homogeneity (constant) variability 
of residues (homoscedasticity), which is one of the 
most significant characteristics influencing the 
BLUE (best linear unbiased estimator) estimate. 
Heteroscedasticity was tested by using Breusch-
Pagan test (Breusch & Pagan, 1979). The outliers 
were tested secondary by using the Bonferroni 
test (Cook & Weisberg, 1982). The non-paramet-
ric Spearman’s rank correlation coefficient ρ was 
used to analyze the relationship. This method was 
selected based on the output of multivariate nor-
mality, using the Royston test of multivariate nor-
mality. Analytical processes were realized by us-
ing the programming language R v 3.6.1 (Action 
of the Toes).
3. RESULTS
The following section of the study is focused 
on the analytical processing leading to the ful-
fillment of the primary objective interpreted in 
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the previous section. The basic characteristics 
of descriptive statistics are shown at the begin-
ning of this section and primarily dealt with 
testing the homogeneity of the variability of re-
siduals. Individual regression models were also 
tested for the presence of significant outliers. 
Subsequently, regression models are shown to 
identify the effect of a country’s innovation on 
tobacco consumption (smoking) and its statisti-
cal significance. Table 1 shows the basic descrip-
tive statistics.
Table 1 shows the basic statistical characteristics 
of the analyzed variables. As it may be deduced, 
the first rows show the number of variables and 
the number of missing values. Data were ana-
lyzed over a period of 8 years (2011–2018), when 
the occurrence of missing values was very fre-
quent (not every country reported/provided se-
lected data for each year). In this case, specific 
characteristics, such as stationarity or autocor-
relation are not a threat that could affect the 
overall output of the model. Outputs of central 
tendency, variability, skewness, kurtosis, and 
quartiles are also shown. These characteristics 
help to complete the overall picture of the ana-
lyzed data.
Three models are involved in the analysis: 
• model 1 determines the effect of GII on G_Tob; 
• model 2 determines the effect of GII on 
Smors_D% 15-24; and 
• model 3 determines the effect of GII on 
Smors_D% 15. 
Table 2 shows the output of homoscedasticity 
testing.
Table 2. Homoscedasticity test – Breusch-Pagan 
statistic
OLS 
model
Breusch-Pagan 
statistic p-value
Significant 
heteroscedasticity
Model 1 35.1740 3.02×10-9 Present
Model 2 0.6868 0.4073 Not present
Model 3 1.4433 0.2296 Not present
Table 2 shows the output of the homoscedastic-
ity test that reveals the variability of residuals. 
Based on a p-value, it may be concluded that the 
assumption of homoscedasticity was not met 
in model 1 (BP = 35.1740; p-value < 0.001). The 
presence of significant outliers was tested us-
ing the Bonferroni Outlier Test, which reveals 
that no significant outliers can be confirmed in 
model 1, model 2, and model 3. 
3.1. The effect of global innovation 
activities on tobacco 
consumption (model 1)
This part of the analysis assesses the assump-
tion that innovation represented by the Global 
Innovation Index affects the tobacco consump-
tion (in grams per person older than 15 years) 
in OECD countries. The simple linear regres-
sion model was applied for statistical processing 
based on the results of the assumption testing. 
The coefficients were estimated by using the 
HC3 estimator. Table 3 shows the test outputs.
Table 3 shows the output of regression model 1, 
using the HC3 estimator. This model indicates 
the p-values of constancy and independent var-
iable less than 0.05. Thus, there is a significant 
effect. The p-values are shown in the last col-
umn. The determination coefficient R2 was ap-
proximately equal to 0.0536, and adjusted R2 
Table 1. Descriptive statistics of variables
Descriptive GII Smors_D%15 Smors_D%15-24 G_Tob
N 288 144 129 143
Missing N 0 144 159 145
Mean 51.15 17.1431 15.0535 1,324.4091
Median 52.62 17.0500 14.8000 1,120.1000
Std. deviation 7.98 4.2979 5.8911 583.7598
Skewness –0.29 0.1173 0.3292 13,983
Kurtosis –0.64 –0.4315 0.2756 2.0613
Q1 45.21 13.8500 11.5000 905.0000
Q3 56.81 19.9750 18.5000 1,625.0000
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was 0.046, i.e., approximately 5% of the depend-
ent variable’s variability, and the independent 
variable determined it. Figure 1 visualizes this 
output.
Figure 1 shows a negative relationship between 
innovation and tobacco consumption. It may be 
assumed that the higher the country’s innovation 
potential, the fewer people consume tobacco.
3.2. The effect of innovation activities 
on the ratio of smokers older 
than 15 years and younger than 
24 years (model 2)
This part of the analysis assesses the assump-
tion that innovation represented by the Global 
Innovation Index affects the ratio of smokers over 
the age of 15 and under the age of 24 years to the 
total population in OECD countries. The simple 
linear regression – Ordinary Least Square (OLS) 
model – was used for statistical processing based 
on the results of the assumption testing. Table 4 
shows the test outputs.
Table 4 shows the output of regression model 2. For 
a residual standard error, it approximately equals to 
5.75 on 127 degrees of freedom, and an F-statistic 
approximately equals to 7.197. This model indicates 
the p-values of constancy and independent varia-
ble of less than 0.05; therefore, there is a significant 
effect. The p-values are shown in the last column. 
The determination coefficient R2 was approximately 
equal to 0.0536, and adjusted R2 was 0.046, i.e., ap-
proximately 5% of the variability of the dependent 
variable, and the independent variable determines 
it. Figure 2 visualizes this output.
Table 3. Regression analysis – model 1
Model 1 – F = 37.43(<0.001)
R2 = 0.21; R2 adj. = 0.20
Estimate Std. error t-value Pr (> |t|)
(Intercept) 3302.80 4.08 810.2 < 2.20×16-10
GII –37.05 0.07 –505.2 < 2.20×10-16
Note: F = 37.43 (< 0.001); R2 = 0.21; R2 adj. = 0.20.
Figure 1. Relationship between GII and G_Tob
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Table 4. Regression analysis – model 2
Model 2 – F = 7.20 (0.008)
R2 = 0.05; R2 adj. = 0.05
Estimate Std. error t-value Pr (> |t|)
(Intercept) 26.21 4.19 6.26 5.55×9-10
GII –0.21 0.08 –2.68 8.28×3-10
Note: F = 7.20 (0.008); R2 = 0.05; R2 adj. = 0.05.
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Figure 2 shows a slightly declining relationship be-
tween innovation and the ratio of smokers over 15 
and under 24 years to the total population. It may 
be assumed that the higher the country’s innova-
tion potential, the lower the ratio of smokers over 
15 and under 24 years to the total population.
3.3. The effect of the innovation 
activities on the ratio of smokers 
older than 15 years (model 3)
This part of the analysis assesses the assump-
tion that innovation represented by the Global 
Innovation Index affects the ratio of smokers over 
the age of 15 to the total population in OECD 
countries. The simple linear regression – Ordinary 
Least Square (OLS) model – was used for statistical 
processing based on the results of the assumption 
testing. The coefficients were estimated by using 
the HC3 estimator. The following Table 5 shows 
the test outputs.
Table 5 shows the output of regression model 3. 
For a residual standard error, it equals to 3.43 
on 138 degrees of freedom and an F-statistic 
approximately equal to 64.31. This model indi-
cates the p-values of constancy and independent 
variable of less than 0.05; therefore, there is a 
significant effect. The p-values are shown in the 
last column. The determination coefficient R2 
was approximately equal to 0.3179 and adjust-
ed R2 was 0.3129, i.e., approximately 32% of the 
variability of the dependent variable, and the in-
dependent variable determines it. Figure 3 visu-
alizes this output.
Figure 3 shows a declining relationship between 
innovation and the ratio of smokers over the age 
of 15 to the total population. It may be assumed 
that the higher the country’s innovation potential, 
the lower the ratio of smokers over the age of 15 to 
the total population.
Correlation analysis was applied to complete 
the picture of the relations, the output is shown 
in Table 5. The table shows the outputs of the 
Royston test of multivariate normality, and this 
condition cannot be confirmed in any case. The 
Spearman’s rank correlation coefficient ρ was 
applied, which determines a significant rela-
Figure 2. Relationship between GII and Smors_D%15-24
5
10
15
20
25
30
35
30,00 35,00 40,00 45,00 50,00 55,00 60,00 65,00 70,00
Da
ily 
sm
ok
ers
 % 
of 
a p
op
ula
tio
n 
15
-24
yea
rs 
Global Innovation index
Table 5. Regression analysis – model 3
Model 3 – F = 64.31(<0.001)
R2 = 0.32; R2 adj. = 0.31
Estimate Std. error t-value Pr (> |t|)
(Intercept) 37.64 2.54 14.79 < 2.20×16-10
GII –0.37 0.05 –8.02 4.07×13-10
Note: F = 64.31(< 0.001); R2 = 0.32; R2 adj. = 0.31.
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tion in all analyzed cases. In all analyzed cases, 
there was a significant negative association, i.e., 
a decrease in smoking indicators can be associ-
ated with an increase in GII.
4. DISCUSSION
Several studies agreed that innovative activities 
reduce smoking (Reychav, McHaney, Hirak, & 
Merker, 2019). On the other hand, these research-
es are only at the micro level, i.e., at the individ-
ual level or specific innovation activities or tech-
nologies. The use of smartphones, apps, eHealth, 
mHealth, or QR codes to reduce smokers is widely 
discussed in many scientific studies (Hoeppner et 
al., 2016; Iacoviello et al., 2017; Peiris et al., 2019; 
Ali, Zhang, & Soomro, 2019; Borrelli, Bartlett, 
Tooley, Armitage, & Wearden, 2015; BinDhim, 
McGeechan, & Trevena, 2014). However, the 
macroeconomic view of the relationship between 
the country’s innovation index and the coun-
try’s overall smoking status is absent. Therefore, 
the macro-level research presented in this study 
was very difficult to relate to significant and rel-
evant scientific sources of information. The pres-
ent study showed that it is possible to talk about 
the effect of innovation (overall at the macro lev-
el – expressed by the GII index) on smoking in 
OECD countries. The rate of smoking is depend-
ent on the innovation output of countries, i.e., less 
smoking in more innovative developed countries. 
The outputs of the relationship analysis indicate 
the existence of a significant negative correlation 
between innovation and selected smoking indi-
cators. Thus, if smoking is reduced, an increase 
in innovation potential can be expected, and vice 
versa. Based on this, the efforts of public policies 
to promote a healthy lifestyle are also welcomed 
through effective marketing (Grier & Bryant, 
2005). At the same time, the country’s higher 
innovation potential can help reduce smoking. 
This study confirms the need to promote inno-
vation in developed economies to reduce smok-
ing. Marketing tools offer a wide range of tools 
that can help promote technological innovation 
(Danaher, Hardie, & Putsis, 2001), as well as mod-
ern smoking cessation technologies. In this way, 
it is possible to increase the country’s innovation 
potential overall.
Figure 3. Relationship between GII and Smors_D%15
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Table 6. Association analysis 
GII G_Tob Smors_D%15-24 Smors_D%15+
Royston MVN 54.47 (< 0.001) 15.49 (< 0.001) 14.15 (< 0.001)
Spearman’s ρ –0.38 (< 0.001) –0.26 (0.003) –0.49 (< 0.001)
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CONCLUSION
This study reveals the relationship between innovation and smoking in developed countries. In both 
cases, marketing is an essential tool to promote the consequences of unhealthy habits, to support efforts 
to reduce smoking, as well as to support innovative smoking cessation technologies. The study’s prima-
ry objective is to determine the effect of innovation on selected smoking indicators in a sample of OECD 
countries. Overall, the results show that the effect of innovation on the ratio of smokers over the age of 
15 to the total population (model 3) may be considered as the relationship with the highest rate of signif-
icance. The effect of innovation on annual tobacco consumption per capita (model 1) is the second most 
significant relationship and the effect of innovation on the ratio of smokers over 15 and under 24 years 
to the total population (model 2) is the least significant when compared to the previous two models. All 
these relations may be considered as negative; thus, it may be assumed that with increasing innovation, 
smoking will decrease. The analysis of the relationship provided similar outputs. It is not possible to de-
termine from the present research which innovative element affects smoking and its intensity. Therefore, 
it is very difficult to highlight any practical implications or recommendations. Future research in this 
field will focus on determining the effect of innovation on smoking from a specific perspective.
Overall, it is possible to confirm a demonstrable relation between innovation potential and smoking. 
Smoking is a negative factor affecting the economy, while the profits from the sale of tobacco prod-
ucts barely cover the costs of lost or limited productivity and treatment of smoking-related diseases. 
Innovations help reduce smoking. Thus, efforts to reduce this negative factor could be more pronounced 
directly to quit smoking, as well as indirectly – by increasing the countries’ innovation potential. From 
this point of view, marketing plays an important role, which can effectively support and promote inno-
vative technologies in the country. The limitation of this study is the nature of the innovation potential 
that indicates the countries’ innovation activities relatively accurately, but generally. Also, not all data 
were available. Despite these limitations, the outputs can be considered as relevant. Future research in 
this area will focus on the perception of prevention activities by smokers and the analysis of the effec-
tiveness of these activities. From a macroeconomic point of view, further research will focus on ver-
ifying the assumptions of the existence of relations between smoking-related indicators and selected 
macroeconomic outputs, such as competitiveness, productivity, or development. 
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